[
  {
    "ts": "2025-11-12T13:30:00+00:00",
    "headline": "Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence",
    "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced it will present data highlighting efficacy, safety and patient-reported outcomes across its portfolio during the 2025 American Society of Dermatologic Surgery (ASDS) Annual Meeting, November 13-16, 2025, in Chicago, Illinois. Oral and video poster presentations, along with expert panels and symposiums, collectively demonstrate Allergan Aesthetics' pioneering scientific research and innovation.",
    "url": "https://finance.yahoo.com/news/allergan-aesthetics-unveils-data-2025-133000288.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "253ada82-cde0-371b-88b3-29b9186f4f47",
      "content": {
        "id": "253ada82-cde0-371b-88b3-29b9186f4f47",
        "contentType": "STORY",
        "title": "Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence",
        "description": "",
        "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced it will present data highlighting efficacy, safety and patient-reported outcomes across its portfolio during the 2025 American Society of Dermatologic Surgery (ASDS) Annual Meeting, November 13-16, 2025, in Chicago, Illinois. Oral and video poster presentations, along with expert panels and symposiums, collectively demonstrate Allergan Aesthetics' pioneering scientific research and innovation.",
        "pubDate": "2025-11-12T13:30:00Z",
        "displayTime": "2025-11-12T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/4591e97f9fa119e687b86928935135e7",
          "originalWidth": 400,
          "originalHeight": 97,
          "caption": "Allergan Aesthetics Logo (PRNewsfoto/AbbVie)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2jrE9cZe71f03h9NEZ6N7g--~B/aD05Nzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/4591e97f9fa119e687b86928935135e7.cf.webp",
              "width": 400,
              "height": 97,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6g_DEIvvGz3NoO_j.dWp7Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/4591e97f9fa119e687b86928935135e7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/allergan-aesthetics-unveils-data-2025-133000288.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/allergan-aesthetics-unveils-data-2025-133000288.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T13:30:00+00:00",
    "headline": "Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders",
    "summary": "PARMA, Italy, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Chiesi Group today announced it has entered into an exclusive license agreement with Aliada Therapeutics, a wholly owned subsidiary of AbbVie, to advance blood-brain barrier (BBB)-crossing platform technology in lysosomal storage disorders (LSD) to address challenging disease areas with high unmet need. “This agreement underscores our continued commitment to creating potential solutions that target the significant unmet needs in managing cognitive",
    "url": "https://finance.yahoo.com/news/chiesi-group-enters-exclusive-license-133000474.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "5290c877-2c38-38f0-8393-eb67a0862940",
      "content": {
        "id": "5290c877-2c38-38f0-8393-eb67a0862940",
        "contentType": "STORY",
        "title": "Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders",
        "description": "",
        "summary": "PARMA, Italy, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Chiesi Group today announced it has entered into an exclusive license agreement with Aliada Therapeutics, a wholly owned subsidiary of AbbVie, to advance blood-brain barrier (BBB)-crossing platform technology in lysosomal storage disorders (LSD) to address challenging disease areas with high unmet need. “This agreement underscores our continued commitment to creating potential solutions that target the significant unmet needs in managing cognitive",
        "pubDate": "2025-11-12T13:30:00Z",
        "displayTime": "2025-11-12T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/da526a07194aed3635e552786e0f8b8e",
          "originalWidth": 700,
          "originalHeight": 466,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Kk7FgGBoQpYv1SWkV5.qCg--~B/aD00NjY7dz03MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/da526a07194aed3635e552786e0f8b8e.cf.webp",
              "width": 700,
              "height": 466,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XElR7OM79ETa7myYXd.lNQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/da526a07194aed3635e552786e0f8b8e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/chiesi-group-enters-exclusive-license-133000474.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/chiesi-group-enters-exclusive-license-133000474.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T11:38:06+00:00",
    "headline": "3 Prominent Stocks Estimated To Be Trading At Discounts Up To 33.7%",
    "summary": "As the U.S. stock market rebounds amid optimism for a resolution to the prolonged government shutdown, investors are eyeing opportunities within this volatile landscape. In such times, identifying undervalued stocks can be crucial for those looking to capitalize on potential discounts, as these stocks may offer significant value relative to their current trading prices.",
    "url": "https://finance.yahoo.com/news/3-prominent-stocks-estimated-trading-113806845.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "4ea2aa97-7015-3be1-aa71-531f26cfb7df",
      "content": {
        "id": "4ea2aa97-7015-3be1-aa71-531f26cfb7df",
        "contentType": "STORY",
        "title": "3 Prominent Stocks Estimated To Be Trading At Discounts Up To 33.7%",
        "description": "",
        "summary": "As the U.S. stock market rebounds amid optimism for a resolution to the prolonged government shutdown, investors are eyeing opportunities within this volatile landscape. In such times, identifying undervalued stocks can be crucial for those looking to capitalize on potential discounts, as these stocks may offer significant value relative to their current trading prices.",
        "pubDate": "2025-11-12T11:38:06Z",
        "displayTime": "2025-11-12T11:38:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/ee047812921f935c11e8b8a18a28c857",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XcwOKB7QsrAPEihissmqcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/ee047812921f935c11e8b8a18a28c857.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_SbGq0fw3Tqr1bi4hnd91g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/ee047812921f935c11e8b8a18a28c857.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-prominent-stocks-estimated-trading-113806845.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-prominent-stocks-estimated-trading-113806845.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BILL"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "RDDT"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "ONB"
            },
            {
              "symbol": "NIC"
            },
            {
              "symbol": "HBAN"
            },
            {
              "symbol": "GENI"
            },
            {
              "symbol": "BUSE"
            },
            {
              "symbol": "FITB"
            },
            {
              "symbol": "CCNE"
            },
            {
              "symbol": "BKNG"
            },
            {
              "symbol": "BYRN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]